Clopidogrel
Back to searchMolecule Structure
Scientific Name
Clopidogrel
Description of the Drug
Clopidogrel is an antiplatelet agent used to prevent blood clots in peripheral vascular disease, coronary artery disease, and cerebrovascular disease.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00758
http://www.drugbank.ca/drugs/DB00758
Brand Name(s)
Grepid, Iscover, Plavix
Company Owner(s)
The Acme Laboratories Ltd, Sun Pharmaceutical Industries Inc, Macleods Pharmaceuticals Ltd, Prinston Pharmaceutical Inc, Torrent Pharmaceuticals Ltd, Rising Pharma Holdings Inc, Graviti Pharmaceuticals Private Ltd, Teva Pharmaceuticals Usa Inc, Accord Healthcare Inc, Ani Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Purinergic receptor P2Y12 | SINGLE PROTEIN | ANTAGONIST | CHEMBL2001 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4769 | ||
PharmGKB | PA449053 | ||
Human Metabolome Database | HMDB0005011 | ||
DrugBank | DB00758 | ||
PubChem: Thomson Pharma | 14899359 | 14923888 | |
PubChem | 60606 | ||
Mcule | MCULE-9061369538 | ||
LINCS | LSM-5415 | ||
Nikkaji | J691.232J | ||
PDBe | CGE | ||
BindingDB | 50318910 | 50397662 | |
EPA CompTox Dashboard | DTXSID6022848 | ||
DrugCentral | 708 | ||
Brenda | 161060 | ||
Guide to Pharmacology | 7150 | ||
rxnorm | CLOPIDOGREL | CLOPIDOGREL BISULFATE | PLAVIX |
ChEBI | 37941 | ||
ZINC | ZINC000034781704 |